Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
暂无分享,去创建一个
[1] J. Cohn,et al. Nitrate effects on cardiac output and left ventricular outflow resistance in chronic congestive heart failure. , 1978, The American journal of medicine.
[2] J. Cohn,et al. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients. , 1977, Annals of internal medicine.
[3] B. Massie,et al. Oral Hydralazine Therapy for Chronic Refractory Heart Failure , 1976, Circulation.
[4] W. Parmley,et al. Combination vasodilator therapy for severe chronic congestive heart failure. , 1976, Annals of internal medicine.
[5] R. Miller,et al. Pharmacological Mechanisms for Left Ventricular Unloading in Clinical Congestive Heart Failure: Differential Effects of Nitropmsside, Phentolamine, and Nitroglycerin on Cardiac Function and Peripheral Circulation , 1976, Circulation research.
[6] E. Alderman,et al. Hemodynamic Consequences of Afterload Reduction in Patients with Chronic Aortic Regurgitation , 1976, Circulation.
[7] J. Cohn,et al. Hemodynamic improvement with hydralazine in left heart failure , 1976 .
[8] K. O’malley,et al. Duration of hydralazine action in hypertension , 1975, Clinical pharmacology and therapeutics.
[9] J. Cohn,et al. Comparative Hemodynamic Effects of Chewable Isosorbide Dinitrate and Nitroglycerin in Patients with Congestive Heart Failure , 1975, Circulation.
[10] R R Miller,et al. Clinical Use of Sodium Nitroprusside in Chronic Ischemic Heart Disease: Effects on Peripheral Vascular Resistance and Venous Tone and on Ventricular Volume, Pump and Mechanical Performance , 1975, Circulation.
[11] Kyuhyun Wang,et al. Hemodynamic Predictors of Myocardial Oxygen Consumption During Static and Dynamic Exercise , 1974, Circulation.
[12] J. Cohn,et al. Treatment of refractory heart failure with infusion of nitroprusside. , 1974, The New England journal of medicine.
[13] S. Shulman,et al. Letter: Transfer-factor therapy of chronic active hepatitis. , 1974, Lancet.
[14] W. Parmley,et al. Hemodynamic and Metabolic Responses to Vasodilator Therapy in Acute Myocardial Infarction , 1973, Circulation.
[15] W. Parmley,et al. Beneficial Effects of Vasodilator Agents in Severe Mitral Regurgitation Due to Dysfunction of Subvalvar Apparatus , 1973, Circulation.
[16] H. Perry. Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis. , 1973, The American journal of medicine.
[17] J. Cohn,et al. IMPROVED LEFT VENTRICULAR FUNCTION DURING NITROPRUSSIDE INFUSION IN ACUTE MYOCARDIAL INFARCTION , 1972 .
[18] G. Diamond,et al. Thermodilution cardiac output determination with a single flow-directed catheter. , 1972, American heart journal.
[19] G. Gensini,et al. Quantitative angiography: the measurement of coronary vasomobility in the intact animal and man. , 1971, Chest.
[20] G. Diamond,et al. Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. , 1970, The New England journal of medicine.
[21] D. Moore-Jones,et al. Radioautographic Localization of Hydralazine-1-C14 in Arterial Walls.∗ , 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[22] J. Cohn. Relationship of plasma volume changes to resistance and capacitance vessel effects of sympathomimetic amines and angiotensin in man. , 1966, Clinical science.
[23] E. Braunwald,et al. The Effects of Nitroglycerin and Amyl Nitrite on Arteriolar and Venous Tone in the Human Forearm , 1965, Circulation.
[24] W. Hollander,et al. The Effects of Intravenous Apresoline (Hydralazine) on Cardiovascular and Renal Function in Patients with and without Congestive Heart Failure , 1956, Circulation.
[25] G. Rowe,et al. The effects of 1-hydrazinophthalazine upon coronary hemodynamics and myocardial oxygen metabolism in essential hypertension. , 1955, The Journal of clinical investigation.